This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benko, D M Articles by Felber, B K Search for Related Content PubMed PubMed Citation Articles by Benko, D M Articles by Felber, B K

 Previous Article  |  Next Article 

J Virol. 1990 June; 64(6): 2505-2518

A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.

National Cancer Institute-Frederick Cancer Research Facility, Maryland 21701-1013.

ABSTRACT

We have characterized a novel 28-kilodalton protein, p28tev, detected in human immunodeficiency virus type 1-infected cells. tev is recognized by both tat and rev monospecific antibodies. tev is initiated at the tat AUG and contains the first exon of tat at its amino terminus, a small portion of env in the middle, and the second exon of rev at its carboxy terminus. A cDNA clone producing tev was cloned and expressed in human cells. Sequence analysis revealed that the tev mRNA is generated by splicing to a novel exon located in the env region. This identifies a fourth class of multiply spliced human immunodeficiency virus mRNAs, produced in infected and transfected cells. tev is regulated during the virus life cycle similarly to the other regulatory proteins, tat, rev, and nef, and displays both tat and rev activities in functional assays. Since tev contains important functional domains of tat and rev and is produced very early after transfection, it may be an important regulator in the initial phase of virus expression. Another rev-related protein, p18(6)Drev, containing env and rev sequences, was characterized and was found not to have detectable rev activity.

This article has been cited by other articles:

• Jablonski, J. A., Buratti, E., Stuani, C., Caputi, M. (2008). The Secondary Structure of the Human Immunodeficiency Virus Type 1 Transcript Modulates Viral Splicing and Infectivity. J. Virol. 82: 8038-8050 [Abstract] [Full Text]  
• Asang, C., Hauber, I., Schaal, H. (2008). Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer. Nucleic Acids Res 36: 1450-1463 [Abstract] [Full Text]  
• Lutzelberger, M., Reinert, L. S., Das, A. T., Berkhout, B., Kjems, J. (2006). A Novel Splice Donor Site in the gag-pol Gene Is Required for HIV-1 RNA Stability. J. Biol. Chem. 281: 18644-18651 [Abstract] [Full Text]  
• Ropers, D., Ayadi, L., Gattoni, R., Jacquenet, S., Damier, L., Branlant, C., Stevenin, J. (2004). Differential Effects of the SR Proteins 9G8, SC35, ASF/SF2, and SRp40 on the Utilization of the A1 to A5 Splicing Sites of HIV-1 RNA. J. Biol. Chem. 279: 29963-29973 [Abstract] [Full Text]  
• Bilodeau, P. S., Domsic, J. K., Mayeda, A., Krainer, A. R., Stoltzfus, C. M. (2001). RNA Splicing at Human Immunodeficiency Virus Type 1 3' Splice Site A2 Is Regulated by Binding of hnRNP A/B Proteins to an Exonic Splicing Silencer Element. J. Virol. 75: 8487-8497 [Abstract] [Full Text]  
• Verhoef, K., Bilodeau, P. S., van Wamel, J. L. B., Kjems, J., Stoltzfus, C. M., Berkhout, B. (2001). Repair of a Rev-Minus Human Immunodeficiency Virus Type 1 Mutant by Activation of a Cryptic Splice Site. J. Virol. 75: 3495-3500 [Abstract] [Full Text]  
• Szilvay, A. M., Bøe, S.-O., Kalland, K.-H. (1999). Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs. J. Gen. Virol. 80: 1965-1974 [Abstract] [Full Text]  
• Lindemann, D., Rethwilm, A. (1998). Characterization of a Human Foamy Virus 170-Kilodalton Env-Bet Fusion Protein Generated by Alternative Splicing. J. Virol. 72: 4088-4094 [Abstract] [Full Text]